02 March 2021>: Articles
Infection-Associated Loss of Vision: A Case Report in a Patient with a History of Intravenous Drug Use
Rare disease
Shirisha Pasula A* , Vichar Trivedi B , Elvisa Loshe B , Pranatharthi Chandrasekar DDOI: 10.12659/AJCR.929116
Am J Case Rep 2021; 22:e929116
Table 2. Antimicrobial susceptibilities of Serratia marcescens.
Antimicrobial | MIC | ET1 susceptibility | Interpretation | Et1 interpretation |
---|---|---|---|---|
Amp/Sulbactam | >16/8 | Resistant | ||
Ampicillin | >16 | Resistant | ||
Aztreonam | ≤1 | Susceptible | ||
Cefazolin | >32 | Resistant | ||
Cefepime | ≤0.5 | Susceptible | ||
Cefoxitin | >16 | Resistant | ||
Ceftazidime | ≤0.5 | Susceptible | ||
Ceftriaxone | ≤0.5 | Susceptible | ||
Ciprofloxacin | 0.12 | Susceptible | ||
Ertapenem | ≤0.125 | Susceptible | ||
Gentamicin | 2 | Susceptible | ||
Imipenem | 1 | Susceptible | ||
Meropenem | ≤0.125 | Susceptible | ||
Piperacillin/Tazobactam | ≤4/4 | Susceptible | ||
Tobramycin | 2 | Susceptible | ||
MIC – minimum inhibitory concentration; ET – epsilometer test. |